Agios Pharmaceuticals Inc (NASDAQ:AGIO)

89.36
Delayed Data
As of May 25
 +0.74 / +0.84%
Today’s Change
45.96
Today|||52-Week Range
92.17
+56.31%
Year-to-Date

Today’s Trading

Previous close88.62
Today’s open88.36
Day’s range88.25 - 89.87
Volume145,561
Average volume (3 months)496,906
Market cap$5.0B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-33.14%
Earnings growth (this year)+3.72%
Earnings growth (next 5 years)--
Revenue growth (last year)-38.46%
P/E ratioNM
Price/Sales61.92
Price/Book11.31

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-2.84-1.80%
ICPTIntercept Pharmaceut...+1.31+1.88%
HCMHutchison China Medi...-1.24-3.95%
MDCOMedicines Co+1.04+3.26%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$1.57
Annual revenue (last year)$43.0M
Annual profit (last year)-$314.7M
Net profit margin-731.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
CFO &
Head-Corporate Development
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts